Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Nester

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Kidney International|September 26, 2025
Strategies for the development of sodium-glucose cotransporter-2 inhibitors for kidney protection in pediatric chronic kidney disease: proceedings of a workshop meeting in July 2023William E Smoyer, Barbara S Gillespie, Louise Oni, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 3, 2024
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work GroupCarla Nester, Dima A Decker, Matthias Meier, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 10, 2023
Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 GenotypesMahmoud Kallash, Yujie Wang, Abigail Smith, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Kidney International|September 26, 2025
Strategies for the development of sodium-glucose cotransporter-2 inhibitors for kidney protection in pediatric chronic kidney disease: proceedings of a workshop meeting in July 2023William E Smoyer, Barbara S Gillespie, Louise Oni, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 3, 2024
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work GroupCarla Nester, Dima A Decker, Matthias Meier, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 10, 2023
Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 GenotypesMahmoud Kallash, Yujie Wang, Abigail Smith, et al.
Pageof 2